Improvement in depressive symptoms after antiretroviral therapy initiation in people with HIV in Rakai, Uganda Noeline NakasujjaAlyssa C. VecchioLeah H. Rubin OriginalPaper 31 July 2021 Pages: 519 - 530
Viruses, SUMO, and immunity: the interplay between viruses and the host SUMOylation system Fergan ImbertDianne Langford Review 03 August 2021 Pages: 531 - 541
Nanoparticles and nanoformulated drugs as promising delivery system in treatment of microbial-induced CNS infection: a systematic review of literature Ali LashkariReza Ranjbar Review 05 July 2021 Pages: 542 - 549
Infectious causes of Alice in Wonderland syndrome Luis Perez-GarciaOriana PachecoAlberto E Paniz Mondolfi Mini-Review 08 June 2021 Pages: 550 - 556
Mitochondrial DNA haplogroups and domain-specific neurocognitive performance in adults with HIV Karen VolpeDavid SamuelsTodd Hulgan OriginalPaper 08 June 2021 Pages: 557 - 567
Psychometric utility of the international HIV dementia scale and Montreal Cognitive Assessment in HIV-associated asymptomatic neurocognitive impairment Stephen L. AitaQuanhathai KaewpoowatNathaniel M. Robbins OriginalPaper 29 June 2021 Pages: 568 - 578
Rates of cognitive impairment in a South African cohort of people with HIV: variation by definitional criteria and lack of association with neuroimaging biomarkers Anna J. DreyerSam NightingaleJohn A. Joska OriginalPaper 09 July 2021 Pages: 579 - 594
Does antiretroviral therapy alter the course of Parkinson’s disease in people living with HIV? Ferzana Hassan AmodAhmed Iqbal BhigjeeAnand Moodley OriginalPaper 05 August 2021 Pages: 595 - 600
Long-term sequelae of herpes simplex virus encephalitis–related white matter injury: correlation of neuropsychological outcome and diffusion tensor imaging Gorky MedhiAnish KapadiaJitender Saini OriginalPaper 16 August 2021 Pages: 601 - 608
Risk factors for neurological complications in children with Flavivirus infection Aline Almeida BentesRoberta Maia de Castro RomanelliErna Geessien Kroon OriginalPaper 03 August 2021 Pages: 609 - 615
Clinical and magnetic resonance imaging patterns of extensive Chikungunya virus–associated myelitis Fernanda Cristina Rueda-LopesLuiz Celso Hygino da CruzSoniza Vieira Alves-Leon Short Communication 05 July 2021 Pages: 616 - 625
Neurological disease caused by Oropouche virus in northern Brazil: should it be included in the scope of clinical neurological diseases? Jannifer O. ChiangRafael S. AzevedoRaimunda S. S. Azevedo Short Communication Open access 11 June 2021 Pages: 626 - 630
Chronic fatigue syndrome: an emerging sequela in COVID-19 survivors? Elisa MantovaniSara MariottoStefano Tamburin Short Communication 02 August 2021 Pages: 631 - 637
Mild encephalitis/encephalopathy with a reversible splenial lesion associated with respiratory syncytial virus infection in infants Xue-Lin LiJinming HanHai-Yang Wang Case Report 05 July 2021 Pages: 638 - 643
Coronavirus disease (COVID-19) complicated by rhino-orbital-cerebral mucormycosis presenting with neurovascular thrombosis: a case report and review of literature Vahid Reza OstovanShirin RezapanahMahtab Rostami Case Report 03 August 2021 Pages: 644 - 649
MRI negative myelopathy post mild SARS-CoV-2 infection: vasculopathy or inflammatory myelitis? Rory M. C. AbramsFarinaz SafaviSusan C. Shin Case Report 08 June 2021 Pages: 650 - 655
COVID-19 leukoencephalopathy with subacute magnetic resonance imaging findings of vasculitis and demyelination Ali VahediSean Apap MangionJulie Chandra Case Report 08 June 2021 Pages: 656 - 661
The importance of thinking about Guillain-Barré syndrome during the COVID-19 pandemic: a case with pure dysautonomic presentation Erica BiassoniAndrea AssiniMassimo Del Sette Case Report Open access 02 August 2021 Pages: 662 - 665